2022 Nomination Deadline is March 4 Wednesday, February 23, 2022 The Canadian Cancer Trials Group is seeking nominations for the 2022 Recognition Awards honouring individuals who have contributed significantly to the mission and activities of the Group. We are seeking nominations for the following Recognition Awards: Founder's Award: Dr. Joseph Pater Excellence in Clinical Trials Research The Founder's Award is presented annually to an investigator whose leadership and body of work has contributed to significant advances in the understanding, diagnosis, treatment, cure, and prevention of cancer. This award honours an Investigator whose excellence in clinical trials research has provided techniques, information or concepts that will direct the future of the oncology research community and the Canadian Cancer Trials Group. Dr. Ralph Meyer Phase III Young Investigator Award The Ralph Meyer Young Investigator Award is presented annually to any MD, fellow, PhD, within 10 years of certification / first faculty appointment or current fellow who has either spent time at Central Office, worked on Phase III projects with Disease Site Committees / Endpoint Committees / Working Groups, or who has contributed significantly to the conduct of a Phase III trial at a centre. Dr. Elizabeth Eisenhauer Early Drug Development Young Investigator Award The Elizabeth Eisenhauer Young Investigator Award is presented annually to any MD, fellow, or PhD, within 7 years of certification / first faculty appointment, or current fellow who has either spent time at Central Office, worked on projects with the Investigational New Drug (IND) Program or who has contributed significantly to the conduct of an IND trial at a centre. Please visit https://www.ctg.queensu.ca/public/recognition-awards for further information about these awards and instructions for nominations. Deadline is March 4, 2022
